Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Goldstone

Showing results (241-250 of 311) with videos related to

Pageof 32
Sort By:
Annals of the Rheumatic Diseases|June 1, 1981
Plasma exchange in systemic lupus erythematosusH F Parry, C J Moran, M L Snaith, et al.
British Journal of Haematology|March 10, 2005
Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusionsD P Hart, I Avivi, K J Thomson, et al.
Haematologica|August 20, 2016
An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantationPaul Ferguson, Robert K Hills, Angela Grech, et al.
British Journal of Haematology|June 8, 2004
Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effectsShirley D'Sa, Kwee Yong, Chara Kyriakou, et al.
Bone Marrow Transplantation|July 1, 1997
Evaluation of clinical scale CD34+ cell purification: experience of 71 immunoaffinity column proceduresM J Watts, A M Sullivan, S J Ings, et al.
British Journal of Haematology|October 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double-blind, placebo-controlled trialA Khwaja, D C Linch, A H Goldstone, et al.
Bone Marrow Transplantation|April 1, 1994
Successful pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocolN Salooja, R Chatterjee, A K McMillan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumabIrit Avivi, Suparno Chakrabarti, Donald W Milligan, et al.
Bone Marrow Transplantation|January 16, 2008
Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantationK J Thomson, K S Peggs, P Smith, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Very high dose chemotherapy with autologous bone marrow rescue in adult patients with resistant relapsed lymphomaC C Anderson, A H Goldstone, R L Souhami, et al.
Pageof 32

Showing results (241-250 of 311) with videos related to

Sort By:
Pageof 32
Annals of the Rheumatic Diseases|June 1, 1981
Plasma exchange in systemic lupus erythematosusH F Parry, C J Moran, M L Snaith, et al.
British Journal of Haematology|March 10, 2005
Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusionsD P Hart, I Avivi, K J Thomson, et al.
Haematologica|August 20, 2016
An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantationPaul Ferguson, Robert K Hills, Angela Grech, et al.
British Journal of Haematology|June 8, 2004
Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effectsShirley D'Sa, Kwee Yong, Chara Kyriakou, et al.
Bone Marrow Transplantation|July 1, 1997
Evaluation of clinical scale CD34+ cell purification: experience of 71 immunoaffinity column proceduresM J Watts, A M Sullivan, S J Ings, et al.
British Journal of Haematology|October 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double-blind, placebo-controlled trialA Khwaja, D C Linch, A H Goldstone, et al.
Bone Marrow Transplantation|April 1, 1994
Successful pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocolN Salooja, R Chatterjee, A K McMillan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumabIrit Avivi, Suparno Chakrabarti, Donald W Milligan, et al.
Bone Marrow Transplantation|January 16, 2008
Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantationK J Thomson, K S Peggs, P Smith, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Very high dose chemotherapy with autologous bone marrow rescue in adult patients with resistant relapsed lymphomaC C Anderson, A H Goldstone, R L Souhami, et al.
Pageof 32